Nuvectis Pharma, Inc. NVCT Unpaid Issuance Costs Related To Offering
Other financials
Where this comes from
Reported directly by Nuvectis Pharma, Inc. in its filing.
Tagged under the XBRL concept nvct:UnpaidIssuanceCostsRelatedToOffering.
The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvectis Pharma, Inc.'s unpaid issuance costs related to offering.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvectis Pharma, Inc.'s unpaid issuance costs related to offering?
- Nuvectis Pharma, Inc. (NVCT) reported unpaid issuance costs related to offering of $300K in Q1 2025.